Your browser doesn't support javascript.
loading
Protocol for Development of American Association of Clinical Endocrinology Clinical Practice Guidelines and Consensus Statements: Summary of Methodology, Process, and Policy - 2023 Update.
Correa, Ricardo; Miragaya, Joanna; Cohen, David A; Hoang, Thanh D; Jasim, Sina; Lieb, David C; Weber, Sandra L; Bird, Melanie D; Stec, Carla.
Afiliação
  • Correa R; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio.
  • Miragaya J; Wellstar Health System, Holly Springs, Georgia.
  • Cohen DA; Division of Endocrinology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Hoang TD; Division of Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland.
  • Jasim S; Division of Endocrinology, Metabolism and Lipid Research, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
  • Lieb DC; Division of Endocrine and Metabolic Conditions, Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
  • Weber SL; University of South Carolina School of Medicine-Greenville, Prisma Health System, Greenville, South Carolina.
  • Bird MD; American Association of Clinical Endocrinology, Jacksonville, Florida.
  • Stec C; American Association of Clinical Endocrinology, Jacksonville, Florida.
Endocr Pract ; 29(5): 341-348, 2023 May.
Article em En | MEDLINE | ID: mdl-37150580
ABSTRACT

OBJECTIVE:

This 2023 updated protocol summarizes the American Association of Clinical Endocrinology's (AACE's) new framework for the development of clinical practice guidelines and other guidance documents that includes changes to methodology, processes, and policies.

METHODS:

AACE has critically reviewed its development processes for guidance documents over the last several years against the National Academy of Medicine Standards for Developing Trustworthy Clinical Practice Guidelines and the Council of Medical Specialty Societies Principles for Development of Specialty Society Clinical Guidelines to determine areas for improvement.

RESULTS:

The new AACE framework for development of guidance documents incorporates many changes, including a revised conflicts of interest (COI) policy; strengthened commitment to collection of disclosures and management of relevant COI during development; open calls to membership for authors; new requirements for authors; new diversity, equity, and inclusion (DEI) policy; new empanelment process that incorporates consideration of DEI; and adoption of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to increase the quality of evidence assessment and standardize recommendation grades and statements, among other improvements.

CONCLUSIONS:

AACE has revised its policies and adopted a completely new methodology for guideline development in support of the mission to elevate the practice of clinical endocrinology to improve patient care. With the use of an evidence-based medicine framework and by continually assessing and improving its processes for development of guidance, AACE strives to deliver trustworthy, unbiased, and up-to-date information that ensures clinician and patient confidence in AACE content. Further, AACE hopes that these enhancements foster a more collaborative approach to development and increase engagement with the worldwide medical community to improve global health.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocrinologia Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endocrinologia Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article